APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiac Glycosides

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cardiac Glycosides Industry Growth and Trends Forecast to 2032

27 December 2025108 pages

Choose your research edition.

Industry ResearchCardiac Glycosides Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac Glycosides Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Cardiac Glycosides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac Glycosides Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac Glycosides Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cardiac Glycosides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cardiac Glycosides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cardiac Glycosides is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiac Glycosides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cardiac Glycosides include Chengdu Beite Pharmaceutical Co., Ltd., Chengdu Haitong Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Pharmaceutical Factory No. 6, China Resources Double Crane Pharmaceutical Co., Ltd., Sanofi, Shandong Weizhi Baike Pharmaceutical Co., Ltd., Shanghai Zhaohui Pharmaceutical Co., Ltd., Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. and Shanghai Xudong Haipu Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cardiac Glycosides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cardiac Glycosides market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cardiac Glycosides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cardiac Glycosides.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cardiac Glycosides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cardiac Glycosides Market by Company

Chengdu Beite Pharmaceutical Co., Ltd.

Chengdu Haitong Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Pharmaceutical Factory No. 6

China Resources Double Crane Pharmaceutical Co., Ltd.

Sanofi

Shandong Weizhi Baike Pharmaceutical Co., Ltd.

Shanghai Zhaohui Pharmaceutical Co., Ltd.

Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd.

Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Cardiac Glycosides Segment by Type

Digoxin

Scutellarin K

Deacetylated Scutellarin

Cardiac Glycosides Segment by Application

Clinic

Hospital

Other

Cardiac Glycosides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac Glycosides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac Glycosides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac Glycosides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cardiac Glycosides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cardiac Glycosides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Digoxin Table 2. Major Company of Scutellarin K Table 3. Major Company of Deacetylated Scutellarin Table 4. Global Cardiac Glycosides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cardiac Glycosides Sales by Type (2021-2026) & (K Units) Table 6. Global Cardiac Glycosides Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cardiac Glycosides Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cardiac Glycosides Sales Market Share in Value by Type (2021-2026) Table 9. Global Cardiac Glycosides Price by Type (2021-2026) & (US$/Unit) Table 10. Global Cardiac Glycosides Sales by Type (2027-2032) & (K Units) Table 11. Global Cardiac Glycosides Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cardiac Glycosides Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cardiac Glycosides Sales Market Share in Value by Type (2027-2032) Table 14. Global Cardiac Glycosides Price by Type (2027-2032) & (US$/Unit) Table 15. North America Cardiac Glycosides Sales by Type (2021-2026) & (K Units) Table 16. North America Cardiac Glycosides Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cardiac Glycosides Sales by Type (2021-2026) & (K Units) Table 18. Europe Cardiac Glycosides Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cardiac Glycosides Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Cardiac Glycosides Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cardiac Glycosides Sales by Type (2021-2026) & (K Units) Table 22. Latin America Cardiac Glycosides Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cardiac Glycosides Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Cardiac Glycosides Sales by Type (2021-2026) & (US$ Million) Table 25. Cardiac Glycosides Industry Trends Table 26. Cardiac Glycosides Industry Drivers Table 27. Cardiac Glycosides Industry Opportunities and Challenges Table 28. Cardiac Glycosides Industry Restraints Table 29. Global Cardiac Glycosides Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cardiac Glycosides Revenue Market Share by Company (2021-2026) Table 31. Global Cardiac Glycosides Sales by Company (2021-2026) & (K Units) Table 32. Global Cardiac Glycosides Sales Share by Company (2021-2026) Table 33. Global Cardiac Glycosides Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Cardiac Glycosides Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cardiac Glycosides Major Company Production Sites and Headquarters Table 36. Global Cardiac Glycosides Company, Product Type & Application Table 37. Global Cardiac Glycosides Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cardiac Glycosides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cardiac Glycosides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cardiac Glycosides Sales by Region (2021-2026) & (K Units) Table 42. Global Cardiac Glycosides Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cardiac Glycosides Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cardiac Glycosides Sales Market Share in Value by Region (2021-2026) Table 45. Global Cardiac Glycosides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Cardiac Glycosides Sales by Region (2027-2032) & (K Units) Table 47. Global Cardiac Glycosides Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cardiac Glycosides Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cardiac Glycosides Sales Market Share in Value by Region (2027-2032) Table 50. Global Cardiac Glycosides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Cardiac Glycosides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cardiac Glycosides Sales by Application (2021-2026) & (K Units) Table 53. Global Cardiac Glycosides Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cardiac Glycosides Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cardiac Glycosides Sales Market Share in Value by Application (2021-2026) Table 56. Global Cardiac Glycosides Price by Application (2021-2026) & (US$/Unit) Table 57. Global Cardiac Glycosides Sales by Application (2027-2032) & (K Units) Table 58. Global Cardiac Glycosides Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cardiac Glycosides Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cardiac Glycosides Sales Market Share in Value by Application (2027-2032) Table 61. Global Cardiac Glycosides Price by Application (2027-2032) & (US$/Unit) Table 62. North America Cardiac Glycosides Sales by Application (2021-2026) & (K Units) Table 63. North America Cardiac Glycosides Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cardiac Glycosides Sales by Application (2021-2026) & (K Units) Table 65. Europe Cardiac Glycosides Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cardiac Glycosides Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Cardiac Glycosides Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cardiac Glycosides Sales by Application (2021-2026) & (K Units) Table 69. Latin America Cardiac Glycosides Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cardiac Glycosides Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Cardiac Glycosides Sales by Application (2021-2026) & (US$ Million) Table 72. Chengdu Beite Pharmaceutical Co., Ltd. Company Information Table 73. Chengdu Beite Pharmaceutical Co., Ltd. Business Overview Table 74. Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio Table 76. Chengdu Beite Pharmaceutical Co., Ltd. Recent Development Table 77. Chengdu Haitong Pharmaceutical Co., Ltd. Company Information Table 78. Chengdu Haitong Pharmaceutical Co., Ltd. Business Overview Table 79. Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio Table 81. Chengdu Haitong Pharmaceutical Co., Ltd. Recent Development Table 82. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Company Information Table 83. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Business Overview Table 84. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Product Portfolio Table 86. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Recent Development Table 87. China Resources Double Crane Pharmaceutical Co., Ltd. Company Information Table 88. China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview Table 89. China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio Table 91. China Resources Double Crane Pharmaceutical Co., Ltd. Recent Development Table 92. Sanofi Company Information Table 93. Sanofi Business Overview Table 94. Sanofi Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sanofi Cardiac Glycosides Product Portfolio Table 96. Sanofi Recent Development Table 97. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Company Information Table 98. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Business Overview Table 99. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio Table 101. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Recent Development Table 102. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information Table 103. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview Table 104. Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio Table 106. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Development Table 107. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Company Information Table 108. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Business Overview Table 109. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio Table 111. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Recent Development Table 112. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Company Information Table 113. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Business Overview Table 114. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio Table 116. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Recent Development Table 117. Southwest Pharmaceutical Co., Ltd. Company Information Table 118. Southwest Pharmaceutical Co., Ltd. Business Overview Table 119. Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio Table 121. Southwest Pharmaceutical Co., Ltd. Recent Development Table 122. North America Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Cardiac Glycosides Sales by Country (2021-2026) & (K Units) Table 124. North America Cardiac Glycosides Sales Market Share by Country (2021-2026) Table 125. North America Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Cardiac Glycosides Sales Market Share Forecast by Country (2027-2032) Table 127. North America Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Cardiac Glycosides Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Cardiac Glycosides Market Share by Country (2021-2026) Table 130. North America Cardiac Glycosides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Cardiac Glycosides Market Share Forecast by Country (2027-2032) Table 132. Europe Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Cardiac Glycosides Sales by Country (2021-2026) & (K Units) Table 134. Europe Cardiac Glycosides Sales Market Share by Country (2021-2026) Table 135. Europe Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Cardiac Glycosides Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Cardiac Glycosides Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Cardiac Glycosides Market Share by Country (2021-2026) Table 140. Europe Cardiac Glycosides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Cardiac Glycosides Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Cardiac Glycosides Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Cardiac Glycosides Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Cardiac Glycosides Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Cardiac Glycosides Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Cardiac Glycosides Market Share by Country (2021-2026) Table 150. Asia-Pacific Cardiac Glycosides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Cardiac Glycosides Market Share Forecast by Country (2027-2032) Table 152. Latin America Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Cardiac Glycosides Sales by Country (2021-2026) & (K Units) Table 154. Latin America Cardiac Glycosides Sales Market Share by Country (2021-2026) Table 155. Latin America Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Cardiac Glycosides Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Cardiac Glycosides Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Cardiac Glycosides Market Share by Country (2021-2026) Table 160. Latin America Cardiac Glycosides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Cardiac Glycosides Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Cardiac Glycosides Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Cardiac Glycosides Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Cardiac Glycosides Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Cardiac Glycosides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Cardiac Glycosides Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Cardiac Glycosides Market Share by Country (2021-2026) Table 170. Middle East and Africa Cardiac Glycosides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Cardiac Glycosides Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Cardiac Glycosides Distributors List Table 175. Cardiac Glycosides Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Cardiac Glycosides Image Figure 2. Global Cardiac Glycosides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiac Glycosides Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiac Glycosides Sales (2021-2032) & (K Units) Figure 5. Digoxin Image Figure 6. Global Digoxin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Scutellarin K Image Figure 8. Global Scutellarin K Sales YoY Growth (2021-2032) & (K Units) Figure 9. Deacetylated Scutellarin Image Figure 10. Global Deacetylated Scutellarin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Cardiac Glycosides Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cardiac Glycosides Market Share by Type 2025 VS 2032 Figure 13. North America Cardiac Glycosides Sales Market Share in Volume by Type in 2025 Figure 14. North America Cardiac Glycosides Sales Market Share in Value by Type in 2025 Figure 15. Europe Cardiac Glycosides Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cardiac Glycosides Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cardiac Glycosides Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cardiac Glycosides Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cardiac Glycosides Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cardiac Glycosides Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cardiac Glycosides Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cardiac Glycosides Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cardiac Glycosides Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Cardiac Glycosides Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cardiac Glycosides Market Share by Application 2025 VS 2032 Figure 33. North America Cardiac Glycosides Sales Market Share in Volume by Application in 2025 Figure 34. North America Cardiac Glycosides Sales Market Share in Value by Application in 2025 Figure 35. Europe Cardiac Glycosides Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cardiac Glycosides Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cardiac Glycosides Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cardiac Glycosides Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cardiac Glycosides Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cardiac Glycosides Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cardiac Glycosides Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cardiac Glycosides Sales Market Share in Value by Application in 2025 Figure 43. North America Cardiac Glycosides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Cardiac Glycosides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cardiac Glycosides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cardiac Glycosides Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cardiac Glycosides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Cardiac Glycosides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cardiac Glycosides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cardiac Glycosides Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cardiac Glycosides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Cardiac Glycosides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cardiac Glycosides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cardiac Glycosides Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cardiac Glycosides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Cardiac Glycosides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cardiac Glycosides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cardiac Glycosides Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cardiac Glycosides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Cardiac Glycosides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cardiac Glycosides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cardiac Glycosides Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cardiac Glycosides Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cardiac Glycosides Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Digoxin
  • Scutellarin K
  • Deacetylated Scutellarin
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Chengdu Beite Pharmaceutical Co., Ltd.
  • Chengdu Haitong Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Pharmaceutical Factory No. 6
  • China Resources Double Crane Pharmaceutical Co., Ltd.
  • Sanofi
  • Shandong Weizhi Baike Pharmaceutical Co., Ltd.
  • Shanghai Zhaohui Pharmaceutical Co., Ltd.
  • Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd.
  • Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiac Glycosides Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cardiac Glycosides Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cardiac Glycosides Market by Type
  6. 1.3.1 Digoxin
  7. 1.3.2 Scutellarin K
  8. 1.3.3 Deacetylated Scutellarin
  9. 1.4 Global Cardiac Glycosides Market Size by Type
  10. 1.4.1 Global Cardiac Glycosides Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cardiac Glycosides Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cardiac Glycosides Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cardiac Glycosides Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cardiac Glycosides Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cardiac Glycosides Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cardiac Glycosides Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cardiac Glycosides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cardiac Glycosides Industry Trends
  2. 2.2 Cardiac Glycosides Industry Drivers
  3. 2.3 Cardiac Glycosides Industry Opportunities and Challenges
  4. 2.4 Cardiac Glycosides Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cardiac Glycosides Revenue (2021-2026)
  2. 3.2 Global Top Players by Cardiac Glycosides Sales (2021-2026)
  3. 3.3 Global Top Players by Cardiac Glycosides Price (2021-2026)
  4. 3.4 Global Cardiac Glycosides Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cardiac Glycosides Major Company Production Sites & Headquarters
  6. 3.6 Global Cardiac Glycosides Company, Product Type & Application
  7. 3.7 Global Cardiac Glycosides Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cardiac Glycosides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cardiac Glycosides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cardiac Glycosides Tier 1, Tier 2, and Tier 3
4 Cardiac Glycosides Regional Status and Outlook
  1. 4.1 Global Cardiac Glycosides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cardiac Glycosides Historic Market Size by Region
  3. 4.2.1 Global Cardiac Glycosides Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cardiac Glycosides Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cardiac Glycosides Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cardiac Glycosides Forecasted Market Size by Region
  7. 4.3.1 Global Cardiac Glycosides Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cardiac Glycosides Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cardiac Glycosides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cardiac Glycosides by Application
  1. 5.1 Cardiac Glycosides Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Cardiac Glycosides Market Size by Application
  6. 5.2.1 Global Cardiac Glycosides Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cardiac Glycosides Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cardiac Glycosides Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cardiac Glycosides Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cardiac Glycosides Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cardiac Glycosides Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cardiac Glycosides Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cardiac Glycosides Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chengdu Beite Pharmaceutical Co., Ltd.
  2. 6.1.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Chengdu Beite Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio
  6. 6.1.5 Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Chengdu Haitong Pharmaceutical Co., Ltd.
  8. 6.2.1 Chengdu Haitong Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Chengdu Haitong Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio
  12. 6.2.5 Chengdu Haitong Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6
  14. 6.3.1 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Company Information
  15. 6.3.2 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Business Overview
  16. 6.3.3 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Product Portfolio
  18. 6.3.5 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Recent Developments
  19. 6.4 China Resources Double Crane Pharmaceutical Co., Ltd.
  20. 6.4.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio
  24. 6.4.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Cardiac Glycosides Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Shandong Weizhi Baike Pharmaceutical Co., Ltd.
  32. 6.6.1 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio
  36. 6.6.5 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shanghai Zhaohui Pharmaceutical Co., Ltd.
  38. 6.7.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio
  42. 6.7.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd.
  44. 6.8.1 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio
  48. 6.8.5 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
  50. 6.9.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio
  54. 6.9.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Southwest Pharmaceutical Co., Ltd.
  56. 6.10.1 Southwest Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolio
  60. 6.10.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Cardiac Glycosides Sales by Country
  2. 7.1.1 North America Cardiac Glycosides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cardiac Glycosides Sales by Country (2021-2026)
  4. 7.1.3 North America Cardiac Glycosides Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cardiac Glycosides Market Size by Country
  6. 7.2.1 North America Cardiac Glycosides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cardiac Glycosides Market Size by Country (2021-2026)
  8. 7.2.3 North America Cardiac Glycosides Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cardiac Glycosides Sales by Country
  2. 8.1.1 Europe Cardiac Glycosides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cardiac Glycosides Sales by Country (2021-2026)
  4. 8.1.3 Europe Cardiac Glycosides Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cardiac Glycosides Market Size by Country
  6. 8.2.1 Europe Cardiac Glycosides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cardiac Glycosides Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cardiac Glycosides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cardiac Glycosides Sales by Country
  2. 9.1.1 Asia-Pacific Cardiac Glycosides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cardiac Glycosides Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cardiac Glycosides Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cardiac Glycosides Market Size by Country
  6. 9.2.1 Asia-Pacific Cardiac Glycosides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cardiac Glycosides Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cardiac Glycosides Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cardiac Glycosides Sales by Country
  2. 10.1.1 South America Cardiac Glycosides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cardiac Glycosides Sales by Country (2021-2026)
  4. 10.1.3 South America Cardiac Glycosides Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cardiac Glycosides Market Size by Country
  6. 10.2.1 South America Cardiac Glycosides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cardiac Glycosides Market Size by Country (2021-2026)
  8. 10.2.3 South America Cardiac Glycosides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cardiac Glycosides Sales by Country
  2. 11.1.1 Middle East and Africa Cardiac Glycosides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cardiac Glycosides Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cardiac Glycosides Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cardiac Glycosides Market Size by Country
  6. 11.2.1 Middle East and Africa Cardiac Glycosides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cardiac Glycosides Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cardiac Glycosides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cardiac Glycosides Value Chain Analysis
  2. 12.1.1 Cardiac Glycosides Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cardiac Glycosides Production Mode & Process
  7. 12.2 Cardiac Glycosides Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cardiac Glycosides Distributors
  10. 12.2.3 Cardiac Glycosides Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst